Abbott Laboratories (ABT) engages in the discovery, development, manufacture, and sale of a line of health care and pharmaceutical products. Below you will find selected information from Value Line. Use the Value Line estimated 2012 figures as the actual year-end figures for the company. The beta reported was .7 and the risk-free rate was 5.13 percent. Assume a market risk premium of 9 percent.

The high and low share price each year were:

		2008		2009		2010		2011		2012
High	$	51	$	54.9	$	60.0	$	63.1	$	57.4
Low		39		47.4		46.3		45.8		44.3

Using the P/E, P/CF, and P/S ratios, estimate the 2013 share price for Abbott Laboratories. Use the average stock price each year to calculate the price ratios. (Do not round intermediate calculations. Round your answers to 2 decimal places. Omit the "$" sign in your response.)

Price ratio
P/E	$
P/CF	$
P/S	$

Abbott Laboratories (ABT) engages in the discovery, development, manufacture, and sale of a line of health care and pharmaceutical products. Below you will find selected information from Value Line. Use the Value Line estimated 2012 figures as the actual year-end figures for the company. The beta reported was .7 and the risk-free rate was 5.13 percent. Assume a market risk premium of 9 percent. The high and low share price each year were: 200 8 High Low $ 51 39 $ 200 9 54. 9 47. 4 $ 201 0 60. 0 46. 3 $ 201 1 63. 1 45. 8 $ 201 2 57. 4 44. 3 Using the P/E, P/CF, and P/S ratios, estimate the 2013 share price for Abbott Laboratories. Use the average stock price each year to calculate the price ratios. (Do not round intermediate calculations. Round your answers to 2 decimal places. Omit the "$" sign in your response.) Price ratio P/E P/CF P/S $ $ $